Quality Systems – Page 29

Transport qualification gaps during distribution qualification – product quality risk assessment

“`html Addressing Gaps in Transport Qualification During Distribution Qualification to Ensure Product Quality Pharmaceutical professionals often face challenges related to transport qualification gaps during the distribution qualification process. These gaps…

Data backup and restore failure during system operation – CAPA and revalidation strategy

Investigating Data Backup and Restore Failures During System Operation: A CAPA Approach Data backup and restore failures during system operation can pose significant risks to pharmaceutical manufacturing integrity and compliance.…

Inventory control failure during storage – product quality risk assessment

Assessing Product Quality Risks Related to Inventory Control Failures During Storage Inventory control failures during storage can lead to significant product quality risks, potentially impacting compliance with Good Manufacturing Practice…

CSV not aligned to actual use during validation lifecycle – CAPA and revalidation strategy

Investigation of CSV Misalignment during the Validation Lifecycle in Pharma Operations In the complex environment of pharmaceutical manufacturing and quality assurance, compliance with Good Manufacturing Practices (GMP) is paramount. A…

Transport qualification gaps during audit – regulatory inspection outcome

Understanding and Addressing Transport Qualification Gaps During Audit Outcomes Transport qualification is a critical component of ensuring that pharmaceutical products remain compliant with Good Manufacturing Practices (GMP) throughout the supply…

CSV not aligned to actual use during system upgrades – preventing repeat CSV observations

Understanding the Impact of Inconsistent CSV During System Upgrades in Pharmaceutical Operations In the highly regulated pharmaceutical industry, the alignment of Computer System Validation (CSV) with actual operational use is…

Supplier change unqualified during storage – how to prevent repeat excursions

Managing Unqualified Supplier Changes During Storage to Prevent Future Excursions In pharmaceutical manufacturing, maintaining the integrity of products throughout the supply chain is paramount. When there is a supplier change…

System access control failure during validation lifecycle – FDA/EMA expectations for computerized systems

Evaluating System Access Control Failures During the Validation Lifecycle In today’s highly regulated pharmaceutical environment, the integrity and security of computerized systems are paramount. A system access control failure can…

Supplier change unqualified during storage – product quality risk assessment

Assessing Product Quality Risks Due to Unqualified Supplier Changes During Storage In today’s complex pharmaceutical landscape, managing supplier qualifications effectively is critical for ensuring product integrity. However, scenarios may arise…

System access control failure during inspection walkthrough – FDA/EMA expectations for computerized systems

Addressing System Access Control Failures During Inspection Walkthroughs: An Investigation Approach Pharmaceutical manufacturers often encounter system access control failures during regulatory inspections, which can impact compliance with Good Manufacturing Practices…

Excursion trend ignored during inspection – CAPA and system remediation

Investigating Ignored Excursion Trends During Inspections In the world of pharmaceutical manufacturing, oversight of critical excursions can lead to significant compliance issues that affect product quality and patient safety. Recent…

Audit trail gaps identified during system upgrades – inspection evidence pack preparation

Identifying Audit Trail Gaps During System Upgrades: A Comprehensive Investigation Guide Audit trails are critical in ensuring data integrity within pharmaceutical operations, serving as a backbone for compliance with regulatory…